Biotech Investors & VC Firms in Asia-Pacific
571 firms in this list, with a median first check of $650K. 110 of them lead rounds. Generated from verified public data and updated continuously.
IT-Farm Corporation
TokyoSeed–Series A
1 person
TrueLight Capital
SingaporeSeed–Late Stage
28 people
Blue Ocean Capital Group
ShenzhenLate Stage
23 people
Crescent Capital Partners
SydneySeries A–Late Stage$13.2M – $52.8M
24 people
Endiya Partners
HyderabadPre-Seed–Series A
9 people
Xeraya Capital
Kuala LumpurSeed–Growth
24 people
JC Capital
BeijingPre-Seed–Series A
11 people
LVX Ventures
BangalorePre-Seed–Late Stage$179K – $10M
Thorney Investment Group
MelbourneSeed–Late Stage
25 people
Hiroshima Venture Capital Co. Ltd.
HiroshimaPre-Seed–Late Stage
New Alliance Capital
ShanghaiSeed–Late Stage
25 people
GSR United Capital
BeijingSeed–Late Stage$98K – $50M
Sprout
Palmerston NorthPre-Seed–Seed
21 people
DG Incubation
Pre-Seed–Growth
Kyoto University Innovation Capital
KyotoPre-Seed–Growth
Quan Capital
ShanghaiSeed–Late Stage
16 people
Expara
SingaporePre-Seed–Series A$320K – $600K
18 people
MedTech Actuator
Seed–Series B
GS Futures
SeoulSeed–Series A
13 people
AN Venture Partners
TokyoPre-Seed–Growth
22 people
Prime Partners
TokyoPre-Seed–Growth
4 people
Waseda University Ventures
TokyoPre-Seed–Growth
15 people
Xiang He Capital
BeijingSeed–Growth
Vertex Venture Management Pte. Ltd.
SingaporePre-Seed–Growth
23 people
Related lists
Investors & VC Firms in North America (14143)Investors & VC Firms in United States (13281)Investors & VC Firms in Europe (5575)Crypto & Web3 Investors & VC Firms (4830)Investors & VC Firms in Global (4158)SaaS Investors & VC Firms (3865)AI & Machine Learning Investors & VC Firms (3769)Fintech Investors & VC Firms (3726)Investors & VC Firms in Asia-Pacific (3574)Healthtech Investors & VC Firms (3415)
Data sourced from public filings and firms' own websites — see our methodology.




























































/f/233941/5455x4091/3b9777c68f/chow-shangwei.jpg)
